Display options
Share it on

World J Clin Cases. 2015 May 16;3(5):430-41. doi: 10.12998/wjcc.v3.i5.430.

Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management.

World journal of clinical cases

Petra Bogovic, Franc Strle

Affiliations

  1. Petra Bogovic, Franc Strle, Department of Infectious Diseases, University Medical Center Ljubljana, 1525 Ljubljana, Slovenia.

PMID: 25984517 PMCID: PMC4419106 DOI: 10.12998/wjcc.v3.i5.430

Abstract

Tick-borne encephalitis is an infection of central nervous system caused by tick-borne encephalitis virus transmitted to humans predominantly by tick bites. During the last few decades the incidence of the disease has been increasing and poses a growing health problem in almost all endemic European and Asian countries. Most cases occur during the highest period of tick activity, in Central Europe mainly from April to November. Tick-borne encephalitis is more common in adults than in children. Clinical spectrum of the disease ranges from mild meningitis to severe meningoencephalitis with or without paralysis. Rare clinical manifestations are an abortive form of the disease and a chronic progressive form. A post-encephalitic syndrome, causing long-lasting morbidity that often affects the quality of life develops in up to 50% of patients after acute tick-borne encephalitis. Clinical course and outcome vary by subtype of tick-borne encephalitis virus (the disease caused by the European subtype has milder course and better outcome than the disease caused by Siberian and Far-Easter subtypes), age of patients (increasing age is associated with less favorable outcome), and host genetic factors. Since clinical features and laboratory results of blood and cerebrospinal fluid are nonspecific, the diagnosis must be confirmed by microbiologic findings. The routine laboratory confirmation of the tick-borne encephalitis virus infection is based mainly on the detection of specific IgM and IgG antibodies in serum (and cerebrospinal fluid), usually by enzyme-linked immunosorbent assay. There is no specific antiviral treatment for tick-borne encephalitis. Vaccination can effectively prevent the disease and is indicated for persons living in or visiting tick-borne encephalitis endemic areas.

Keywords: Clinical manifestations; Diagnosis; Epidemiology; Prevention/vaccination; Tick-borne encephalitis; Treatment

References

  1. Scand J Infect Dis. 1998;30(5):509-12 - PubMed
  2. Vaccine. 2010 Apr 1;28(16):2827-31 - PubMed
  3. J Neurol. 1999 Dec;246(12):1169-71 - PubMed
  4. J Gen Virol. 1999 Jan;80 ( Pt 1):179-85 - PubMed
  5. Clin Infect Dis. 2002 Sep 15;35(6):650-8 - PubMed
  6. J Gen Virol. 2009 Dec;90(Pt 12):2884-92 - PubMed
  7. Neurocrit Care. 2004;1(2):219-33 - PubMed
  8. Wien Klin Wochenschr. 2002 Jul 31;114(13-14):627-9 - PubMed
  9. J Infect. 1991 Jan;22(1):81-6 - PubMed
  10. Scand J Infect Dis. 1996;28(3):217-24 - PubMed
  11. Clin Neurol Neurosurg. 2009 Jun;111(5):399-406 - PubMed
  12. Vaccine. 2003 Apr 1;21 Suppl 1:S11-8 - PubMed
  13. Euro Surveill. 2008 Jun 26;13(26):null - PubMed
  14. Emerg Infect Dis. 2005 Mar;11(3):485-8 - PubMed
  15. Lancet. 2012 Feb 4;379(9814):461-73 - PubMed
  16. Virus Res. 2005 Aug;111(2):161-74 - PubMed
  17. J Intern Med. 1989 Mar;225(3):173-7 - PubMed
  18. Wien Klin Wochenschr. 2002 Jul 31;114(13-14):623-6 - PubMed
  19. Med Parazitol (Mosk). 2010 Jan-Mar;(1):53-9 - PubMed
  20. Vaccine. 2009 Nov 23;27(50):7021-6 - PubMed
  21. J Neurovirol. 2006 Aug;12(4):322-7 - PubMed
  22. Nat Clin Pract Rheumatol. 2007 Jan;3(1):20-5 - PubMed
  23. Int J Med Microbiol. 2006 May;296 Suppl 40:208-12 - PubMed
  24. Clin Infect Dis. 2001 Aug 15;33(4):503-10 - PubMed
  25. Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun;(3):33-6 - PubMed
  26. Travel Med Infect Dis. 2010 Jul;8(4):223-32 - PubMed
  27. Antiviral Res. 2012 Jan;93(1):64-8 - PubMed
  28. Eur J Pediatr. 1996 Sep;155(9):775-9 - PubMed
  29. Wkly Epidemiol Rec. 2011 Jun 10;86(24):241-56 - PubMed
  30. Wien Med Wochenschr. 2012 Jun;162(11-12):229 - PubMed
  31. J Infect Dis. 2010 Dec 15;202(12 ):1813-8 - PubMed
  32. Infection. 1998 May-Jun;26(3):160-4 - PubMed
  33. Euro Surveill. 2011 Sep 29;16(39):null - PubMed
  34. Eur J Med Res. 2006 Jun 30;11(6):261-5 - PubMed
  35. Vaccine. 2003 Apr 1;21 Suppl 1:S19-35 - PubMed
  36. Clin Infect Dis. 1999 Apr;28(4):882-90 - PubMed
  37. Vet Microbiol. 2010 Jan 27;140(3-4):221-8 - PubMed
  38. Eur J Clin Microbiol Infect Dis. 1992 Oct;11(10):894-900 - PubMed
  39. Emerg Infect Dis. 2013 May;19(5):806-8 - PubMed
  40. Vector Borne Zoonotic Dis. 2011 Jun;11(6):659-64 - PubMed
  41. Wien Klin Wochenschr. 2006 Nov;118(21-22):702-7 - PubMed
  42. Infect Dis Clin North Am. 2008 Sep;22(3):561-75, x - PubMed
  43. J Neurol Neurosurg Psychiatry. 2007 Aug;78(8):909-10 - PubMed
  44. J Infect Dis. 2008 Jan 15;197(2):266-9 - PubMed
  45. Infection. 2000 Mar-Apr;28(2):78-84 - PubMed
  46. J Gen Virol. 2009 Aug;90(Pt 8):1781-94 - PubMed
  47. Vaccine. 2008 Feb 13;26(7):863-8 - PubMed
  48. J Clin Virol. 2005 Aug;33(4):331-5 - PubMed
  49. J Travel Med. 2004 Sep-Oct;11(5):307-12 - PubMed
  50. Hum Vaccin Immunother. 2013 Feb;9(2):362-74 - PubMed
  51. Epidemiol Mikrobiol Imunol. 2009 Apr;58(2):98-103 - PubMed
  52. Acta Med Croatica. 2009 Oct;63(4):269-78 - PubMed
  53. Travel Med Infect Dis. 2003 Aug;1(3):181-4 - PubMed
  54. Eur J Pediatr. 2010 Jun;169(6):767-9 - PubMed
  55. Infection. 1983 May-Jun;11(3):164-6 - PubMed
  56. Infection. 2000 Mar-Apr;28(2):74-7 - PubMed
  57. Infection. 2007 Feb;35(1):26-9 - PubMed
  58. Ticks Tick Borne Dis. 2011 Mar;2(1):2-15 - PubMed
  59. Expert Rev Anti Infect Ther. 2009 Dec;7(10):1251-60 - PubMed
  60. Lancet. 1995 Dec 2;346(8988):1502 - PubMed
  61. Wien Klin Wochenschr. 2002 Jul 31;114(13-14):636-40 - PubMed
  62. J Clin Virol. 2012 Jun;54(2):115-20 - PubMed
  63. Euro Surveill. 2010 Jul 08;15(27):24-31 - PubMed
  64. Lancet. 2008 May 31;371(9627):1861-71 - PubMed
  65. Dtsch Med Wochenschr. 1986 May 30;111(22):861-4 - PubMed
  66. Clin Diagn Virol. 1997 May;8(1):17-29 - PubMed
  67. J Clin Virol. 2012 Dec;55(4):289-95 - PubMed
  68. Eur J Neurol. 2011 May;18(5):673-9 - PubMed
  69. Fortschr Neurol Psychiatr. 2009 Oct;77(10):591-3 - PubMed
  70. Nervenarzt. 2000 Feb;71(2):112-5 - PubMed
  71. Vaccine. 2003 Apr 1;21 Suppl 1:S50-5 - PubMed
  72. J Clin Virol. 2009 Jun;45(2):125-8 - PubMed
  73. Pediatr Infect Dis J. 2003 Jul;22(7):612-7 - PubMed
  74. BMC Infect Dis. 2013 Jul 03;13:306 - PubMed
  75. Vaccine. 2003 Apr 1;21 Suppl 1:S36-40 - PubMed
  76. Clin Infect Dis. 1993 Mar;16(3):392-6 - PubMed
  77. Clin Diagn Virol. 1995 Jul;4(1):51-9 - PubMed
  78. Emerg Infect Dis. 2013 Jan;19(1):69-76 - PubMed
  79. Infection. 1995 Jul-Aug;23(4):203-6 - PubMed
  80. Antiviral Res. 2003 Jan;57(1-2):129-46 - PubMed
  81. Emerg Infect Dis. 2008 Feb;14(2):210-6 - PubMed
  82. J Gen Virol. 1997 Nov;78 ( Pt 11):2711-22 - PubMed
  83. Wien Med Wochenschr. 2012 Jun;162(11-12):230-8 - PubMed
  84. Acta Med Croatica. 2003;57(2):111-6 - PubMed
  85. Travel Med Infect Dis. 2010 Jul;8(4):246-50 - PubMed
  86. Pediatr Infect Dis J. 2011 Apr;30(4):355-7 - PubMed
  87. Brain. 1999 Nov;122 ( Pt 11):2067-78 - PubMed
  88. Clin Microbiol Infect. 2012 Oct;18(10):1027-32 - PubMed

Publication Types